TRACY KERZAN: Open Payments
NPI 1629529334 · VINCENNES, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 33 payments from 16 companies in 2025. Trend: 2023 $157 · 2024 $688 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $109 |
| Actelion Pharmaceuticals US, Inc. | 5 | $89 |
| Insmed, Inc. | 4 | $63 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $59 |
| Amgen Inc. | 2 | $33 |
| GENZYME CORPORATION | 2 | $32 |
| Novo Nordisk Inc | 1 | $22 |
| PFIZER INC. | 1 | $20 |
| United Therapeutics Corporation | 1 | $19 |
| Verona Pharma, Inc. | 1 | $18 |
Products named: VERQUVO, UPTRAVI, Arikayce, LifeVest, TEZSPIRE, DUPIXENT, Wegovy, VYNDAQEL.
Industry payments across IN — which companies pay providers there.
